Literature DB >> 2859262

Immunohistochemical localization of adenosine deaminase complexing protein in intestinal mucosa and in colorectal adenocarcinoma as a marker for tumour cell heterogeneity.

J Ten Kate, J T Wijnen, J Boldewijn, P M Khan, F T Bosman.   

Abstract

Adenosine deaminase complexing protein (ADCP), a dimeric glycoprotein, has been reported to be decreased or deficient in transformed or cancer-derived cell lines, indicating its potential significance as an indicator of malignant transformation. A similar deficiency was reported in total homogenates of tumours of colon, kidney, lung and liver. In previous biochemical studies we failed to confirm the consistent reduction in ADCP concentration in cancer tissues. A possible explanation for our findings was thought to be intercellular heterogeneity in ADCP expression in individual tumour cells. To study ADCP expression in individual cells, we developed an immunohistochemical method which was applied to tissue sections. Paraformaldehyde--lysine--periodate (PLP) solution was found to be a suitable fixative. Fixed tissue samples were paraffin-embedded, sectioned and stained for ADCP, using an indirect peroxidase-labelled antibody procedure. The protein was localized in normal colonic mucosa, mainly in the brush border region of the luminal epithelium and in cytoplasmic granules. Intense ADCP immunoreactivity was found also in the basal part of some cells. In cancer cells, three staining patterns were observed: membranous, diffuse cytoplasmic and granular cytoplasmic. The adenocarcinomas exhibited significant intratumour and intertumour heterogeneity in their staining types. Further studies on ADCP expression in colorectal cancer in relation to clinical and histopathological characteristics are warranted in order to fully evaluate the potential significance of ADCP as a cancer associated antigen.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859262     DOI: 10.1007/bf01003400

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  21 in total

1.  Multiple forms of human adenosine deaminase. II. Isolation and properties of a conversion factor from human lung.

Authors:  H Nishihara; S Ishikawa; K Shinkai; H Akedo
Journal:  Biochim Biophys Acta       Date:  1973-04-12

2.  The adenosine deaminase binding protein of human skin fibroblasts is located on the cell surface.

Authors:  R J Andy; R Kornfeld
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

3.  Histologic fixatives suitable for diagnostic light and electron microscopy.

Authors:  E M McDowell; B F Trump
Journal:  Arch Pathol Lab Med       Date:  1976-08       Impact factor: 5.534

Review 4.  Intraneoplastic diversity.

Authors:  D L Dexter; P Calabresi
Journal:  Biochim Biophys Acta       Date:  1982-12-21

5.  Characterization of adenosine deaminase from normal colon and colon tumors. Evidence for tumor-specific variants.

Authors:  P P Trotta; M E Balis
Journal:  Biochemistry       Date:  1978-01-24       Impact factor: 3.162

6.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

7.  Quantitative changes in adenosine deaminase isoenzymes in human colorectal adenocarcinomas.

Authors:  J ten Kate; J T Wijnen; R G van der Goes; R Quadt; G Griffioen; F T Bosman; P M Khan
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

8.  In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties.

Authors:  G Poste; J Doll; I R Hart; I J Fidler
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

9.  Adenosine deaminase complexing protein (ADCP): a transformation sensitive protein with potentials of a cancer marker.

Authors:  E Herbschleb-Voogt; J Ten Kate; P Meera Khan
Journal:  Anticancer Res       Date:  1983 Mar-Apr       Impact factor: 2.480

10.  Selected applications of immunoperoxidase techniques in surgical pathology.

Authors:  C G Espinoza; S G Pillarisetti; H A Azar
Journal:  Ann Clin Lab Sci       Date:  1983 May-Jun       Impact factor: 1.256

View more
  4 in total

1.  In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.

Authors:  Pei-Jun Liu; Chi-De Chen; Chih-Liang Wang; Yi-Cheng Wu; Chia-Wei Hsu; Chien-Wei Lee; Lien-Hung Huang; Jau-Song Yu; Yu-Sun Chang; Chih-Ching Wu; Chia-Jung Yu
Journal:  Mol Cell Proteomics       Date:  2015-01-31       Impact factor: 5.911

2.  Potential of soluble CD26 as a serum marker for colorectal cancer detection.

Authors:  Oscar J Cordero; Monica Imbernon; Loretta De Chiara; Vicenta S Martinez-Zorzano; Daniel Ayude; Maria Paez de la Cadena; F Javier Rodriguez-Berrocal
Journal:  World J Clin Oncol       Date:  2011-06-10

3.  Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior.

Authors:  Ernest Y Tan; Michelle Mujoomdar; Jonathan Blay
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

4.  Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer.

Authors:  O J Cordero; D Ayude; M Nogueira; F J Rodriguez-Berrocal; M P de la Cadena
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.